Next, we have determined that the activation of the EphA3-mediated signaling increases the invasive potential of both BC cells and cancer-associated fibroblasts (CAFs) derived from BC patients, thus contributing to the cooperation between tumor and stromal cells in BC progression. Here, EPHA3 is linked to breast cancer.